Pierre-Alexandre Fournier, CEO of Hexoskin was selected as an Innovation Leader for the #LSIUSA22 Emerging Medtech Summit. Hexoskin's CEO will present at the event on March 15-18, 2022, and announce exciting new products and partnerships aimed to help patients have better access to healthcare.
Pierre-Alexandre has been involved in health sensor development and artificial intelligence projects for over 15 years and advises many public and private organizations on these topics in the US, Canada and Europe. Pierre-Alexandre is also an advocate for transparency in healthcare, patient empowerment, and healthcare innovation through design.
Hexoskin Smart Garments utilize embedded textile sensors to continuously monitor vital signs. Hexoskin smart clothing is capable of monitoring cardiac, pulmonary, activity, and sleep digital biomarkers.
The Emerging Medtech Summit will feature 150 vetted presenting companies, panel sessions, 1:1 meetings, and networking opportunities.
Biomedical researcher Héloïse Auger will talk about Hexoskin's work in space medicine, Astroskin wearable sensors, and artificial intelligence for automated diagnostics at the Healthcare without Boundaries Colloquium this week on June 1-2. Registration is available on Eventbrite: Healthcare without Boundaries Colloquium
Hexoskin has been collaborating with the Canadian Space Agency since 2011 on the development of medical technologies that can be used for human spaceflight. Devices that can record health data passively, like the Astroskin, create an opportunity to develop autonomous medical systems using clinical rules and artificial intelligence to support long-term space missions beyond low Earth orbit.
Today Hexoskin has reached an important milestone. The Hexoskin Connected Health Platform has been used in over 100 scientific & peer-reviewed publications thanks to our community of researchers and scientists dedicated to promoting safe and effective remote monitoring technologies!
But who’s counting? Actually... we do! Our Hexoskin Smart Clothing solutions benefit from the most validation and publications in the industry, accounting for more than all the smart clothing competition combined.
The publications and validations studies cover a wide range of fields of study from scientific validations of the Hexoskin Cardiac, Pulmonary, and Activity smart clothing sensors; to various subjects and health applications.
It’s been such a wonderful experience to reach this milestone and we are thankful for the trust placed in our Hexoskin Connected Health Solutions. We can’t wait to continue this journey to improve evidence-based practice for patients and professionals by bringing science to new levels!
Adoption of mobile and connected health tech in clinical trials is a real-world challenge for pharmaceutical companies. Our CEO Pierre-Alexandre Fournier has shared his thoughts recently about the adoption of mobile and connected health tech with Fierce Pharma.
"The industry needs to get with it now or pay for it later—literally. The reason? Sensor tech will be adopted faster at a large scale in healthcare than in pharma trials, and that means “the drugs you are developing today are going to be seen with tools that you are not using in your trials right now.” That could cost drugmakers billions of dollars if they launch products only to find that monitoring tech turns up real-world outcomes that don’t meet payers’ standards."
Read more on Fierce Pharma.
Medipense announced this week its innovative RxPense medication management and remote monitoring device at the MedTech Conference, and demonstrated its integration with Hexoskin biometric shirts.
“I’m so proud to officially launch the RxPense Nova17, the birth of a new generation in medication dispensing, for those who struggle staying adherent to multiple medications” stated Terry Fagen, President and Founder of Medipense.
"Medipense has a unique solution for medication management, and we're glad they chose Hexoskin as a vital signs monitoring partner. Our companies share a common same vision for connected health and the future in healthcare" says Pierre-Alexandre Fournier, CEO of Hexoskin.
The MedTech Conference is in San Jose, California from September 25th to September 27th 2017.
Medipense is the inventor and manufacturer of RxPense®, an integrated, intelligent and connected medication therapy management and remote monitoring system designed for Seniors, Chronic Care Patients, Disabled Veterans, and those with complex medication regimens.
Hexoskin is the world leader in smart clothing for health monitoring. Hexoskin smart shirts are used by thousands of athletes, trainers, and health professionals all over the world, and provide a new, convenient way to understand human health in real-life environments. In addition to serving its clients in sports science and health research, Hexoskin is a supplier of smart clothing for aerospace and military organizations in many countries, including the United States.
Everyday, first responders put their own lives at risk to help individuals, families, and communities. They experience frontline tragical issues, such as accidents, deaths, murders, etc. In Canada, according to the Tema Conter Memorial Trust, ‘’PTSD, Post Traumatic Stress Disorder, is a very real phenomenon facing over 20% of all First Responders’’ (CASP, 2016).
Health data are useful to get insights about the individual’s vitals. Hexoskin provides the physiological data, which gives an easy access to the vital signs information in order to determine the appropriate prevention solutions. Hexoskin can measure and report in real-time, high-level actionable data such as readiness information; remote dashboard for command center; focus and cognitive assessment; stress and fatigue monitoring; mood status monitoring; energy expenditure and metabolism monitoring.View full article →
Hexoskin is attending the AI in Healthcare Summit in San Francisco this week to present its connected health platform and healthcare AI architecture on Monday, June 26th.
The current hospital system has been built around the treatment of acute illness: emergencies, injuries, infections, etc. Chronic diseases are changing healthcare, and we are now entering a future in which care delivery is becoming decentralized, where communication between health professionals and patients is being facilitated by technology, leading to many potential advancements in prevention, treatment of chronic illness, and much more.
In his talk, Hexoskin's CEO Pierre-Alexandre Fournier discusses the specific tools enabling these advancements, what challenges exist in using health data for AI, and how healthcare professionals can leverage these new technologies to improve the quality of life for chronically ill patients.
The Hexoskin software research platform is designed to generate continuous health data for the development of Artificial Intelligence (machine learning) algorithms for chronic diseases management. Hexoskin also offers AI and data science services to healthcare and pharma companies.
Hexoskin is the world leader in smart clothing and body sensing technologies. The company has announced last year it will equip the International Space Station (ISS) with a bio-monitoring system for astronauts in collaboration with NASA and the Canadian Space Agency.
The Montreal Heart Institute is currently completing a clinical trial with Hexoskin biometric shirts with angina patients undergoing therapy. One of the goals of the study is to develop a new vitality index using Hexoskin biometric shirts to assess angina and to monitor the rehabilitation of cardiac patients.
Hexoskin is the world leader in smart clothing for health monitoring. Hexoskin smart shirts are used by space and defense agencies, sports scientists, and thousands of health professionals and health researchers all over the world. The Hexoskin connected platform provides a new, convenient way to understand human health in real-life environments. For more information, write us at firstname.lastname@example.org, and visit www.hexoskin.com and @Hexoskin on Twitter.
CAUTION - Hexoskin products and services are not intended, and should not be used to investigate, diagnose, monitor, treat or prevent disease or other medical conditions nor to provide information for medical or diagnostic purposes.
Hexoskin is attending the 2017 BIO conference in San Diego this week, and will be demonstrating its connected health platform and biometric shirt at the Quebec pavilion (booth 4315).
The Hexoskin open-data platform enables the development of new digital markers, third-party device integration, ePROs, artificial intelligence and application-specific development.
In order to meet clinical trial development requirements, Hexoskin works in partnership with pharma and biotechs to design efficient protocols for continuous patient monitoring. Clinical areas of interest include those with a need for longitudinal studies in cardiology, respiratory, sleep, CNS, activity, stress, mental illness, etc.
The Hexoskin software research platform is designed to generate continuous health data for the development of Artificial Intelligence (machine learning) algorithms for chronic diseases management. Hexoskin also offers AI and data science services to pharma and biotech companies.
The Department of Homeland Security and Grant County Sheriff’s Office recently tested new technologies for first responders in diverse emergency scenarios in the Gorge Amphitheater in Washington state. Some first responders participating in the program are using Hexoskin to monitor their vitals and their data are transmitted to the command center using smartphones. Read the article ''First Responders test new communications tech in partnership with Homeland Security'' for more information.
As seen in the AARP document, The Longevity Economy – How People Over 50 are Driving Economic and Social Value in the U.S., ‘’early experiments also indicate that Hexoskin may facilitate remote monitoring/telehealth—in uses ranging from ambient assisted living (AAL) to sleep health (Banejee, T. et al., 2015) (…) This reduces both public and individual healthcare costs, and is minimally intrusive for patients.’’
Hexoskin is the only clinically validated system that continuously records ECG with respiratory lung functions and daily/sleep activities. It is used more and more to assess sleep quality at home and in clinical studies. In fact, all the data recorded with Hexoskin are important to consider when it comes to wellness and longevity.
Here is the link to the AARP document: The Longevity Economy
Sleep disorders can have a dramatic impact on a person's health. According to the American College of Cardiology, obstructive sleep apnea affects more than 12 millions American adults which most of the time aren't diagnosed. The relationship between sleep disorders and cardiovascular diseases is well documented.